Skip to main content Accessibility help
×
Home

Prevalence of obesity and metabolic syndrome in a long-stay psychiatric unit

  • Itoro Udo (a1), Mary Mooney (a2) and Alison Newman (a3)

Abstract

Objective: The aim of this study was to determine the prevalence of metabolic syndrome and obesity as defined by Body Mass Index (BMI) in a long-stay psychiatric unit where all care is provided by the psychiatric team.

Method: All residents in this long-stay unit were screened. Their BMI was calculated. Waist circumference and blood investigations were done. Ward records were used to determine those who had been previously diagnosed with hypertension and diabetes. The ATP 111 criteria were used to determine the prevalence of metabolic syndrome.

Results: We found a prevalence of 33% for BMI obesity and a prevalence of 66% for metabolic syndrome. These are higher than those of the general Irish middle aged population and the accepted estimate of a general psychiatric population. It is also higher than that of a previous published study on an Irish long-stay psychiatric ward population.

Conclusion: There is high prevalence of BMI obesity and metabolic syndrome in long-stay psychiatric residents. This has the potential to impact significantly on physical morbidity and mortality. People with severe and enduring mental illness should have access to primary care and other health services on the same basis as any other citizen.

Copyright

Corresponding author

*Correspondence E-mail: itoroime.udo@tewv.nhs.uk

References

Hide All
1.Doherty, DT, Walsh, D, Moran, R. Happy Living Here…A Survey and Evaluation of Community Residential Mental Health Services in Ireland. Dublin: Mental Health Commission; 2007.
2.Rasanen, S, Hakko, H, Viilo, K, Meyer-Rochow, VB, Moring, J. Excess Mortality among Long-Stay Psychiatric Patients in Northern Finland. Soc Psych Psychiatric Epidemi 2003; 38(6): 297304.
3.Brown, S, Barraclough, B, Iniskip, H. Cause of the Excess Mortality in Schizophrenia: A record Linkage Study. Br J Psych 2000;177: 212–7.
4.Osby, U, Correla, N, Brandt, Let al.Mortality and Causes of Death in Stockholm County. Schiz Res 2000; 45(1-2): 21–8.
5.Enger, C, Weatherby, L, Reynolds, RF, Glasser, DBet al.Serious Cardiovascular Events and Mortality Among Patients With Schizophrenia. J Nerv Mental Dis 2004; 192: 1927.
6.Heiskanen, TH, Niskanen, L, Hintikka, JJet al.Metabolic Syndrome and Depression: A Cross- Sectional Analysis. J Clin Psych 2006; 67: 1422–7.
7.Dinan, TG. The Physical Consequences of Depressive Illness. Br J Psych 1999; 318: 826.
8.Jones, LE, Carney, CP. Increased Risk for Metabolic Syndrome in Persons Seeking Care for Mental Disorders. Ann Clin Psych 2008; 18(3): 149–55.
9.Hollins, S, Attard, MT, Von Fraunhofer, Net al.Mortality in People With Learning Disability: Risks, Causes, and Death Certification Findings in London. Develop Med and Child Neurol 1998; 40: 50–6.
10.Lyndsey, M. Comprehensive Health Care Services for People with Learning Disabilities. Adv Psych Treatment 2002; 6: 138–47.
11.Ouellette-Kunz, H, Garcin, N, Lewis, Set al.Addressing Health Disparities through Promoting Equity for Individuals with Intellectual Disability. Queen's University, Kingston, Canada. Health Equity for Intellectually Disabled Individuals Program; 2004 [updated 2004; cited]; Available from: http://www.igh.ualberta.ca/RHD/Synthesis/Disabilities.htm.
12.Marder, SR, Essock, SM, Miller, ALet al.Physical Health Monitoring with Schizophrenia. Am J Psych 2004; 161: 1334–49.
13.Pyorala, K. Metabolic Syndrome- A Myth or Useful Concept. European Society of Cardiology; 2006 [updated 2006; cited]; Available from: http://www.escardio.org/congress/world_congress_cardiology_2006/congressreports/pages/719000_pyorala.aspx.
14Gothe, JW, Szarek, BI, Caley, CF, Wolley, SB. Signs and Symptoms Associated With the Metabolic Syndrome in Psychiatric Inpatients Receiving Antipsychotics: A Retrospective Chart Review. J Clin Psych 2007; 68: 22–8.
15.Toalson, P, Ahmed, S, Hardy, T, Kabinoff, G. The Metabolic Syndrome in Patients With Severe Mental Illness. J Clin Psych 2004; 6: 152–8.
16.Stahl, SM. The Metabolic Syndrome: Psychopharmacologists Should Weigh the Evidence for Weighing the Patient. J Clin Psych 2002; 63: 1094–5.
17.Alexander, CM, Landsman, PB, Teutsch, SM, Haffer, SM. Third National Health and Nutrition Examination Survey (NHANES); National Cholesterol Education Program (NCEP). NCEP Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease among NHANES 111 participants Age 50 and Older. Diabetes 2003; 52: 1210–4.
18.Villegas, R, Perry, U, Creagh, D, Hinchion, R, O'Halloran, D. Prevalence of the Metabolic Syndrome in Middle-aged Men and Women. Diabetes Care 2003; 26: 3198–9.
19.O'Brien, S, Devitt, E, Mohammed, A, Colm, M. High Prevalence of Risk Factors for Physical Illness in a Long-stay Psychiatric Unit. Ir J Psychol Med 2007; 24(2): 55–8.
20.Bazire, S. Psychotropic Drug Directory 2009. Aberdeen: Healthcomm UK Ltd; 2009.
21.Woods, SW. Chlorpromazine Equivalent Doses for the Newer Atypical Antipsychotics. J Clin Psych 2003; 64: 663–7.
22.McEnvoy, JPet al.Prevalence of the Metabolic Syndrome in Patients with Schizophrenia: Baseline Results from the Clinical Antipsychotic Trial of Intervention Effectiveness (CATIE) Schizophrenia Trial and Comparison with National Estimates from NHANES 111. Schiz Res 2005; 80: 1932.
23.Tirupati, S, Chua, L. Obesity and Metabolic Syndrome in a Psychiatric Rehabilitation Service. Aust NZ J Psych 2007; 41(7): 606–10.
24.Department of Health and Children. Survey of Lifestyle, Attitudes and Nutrition in Ireland 2007: Dietary Habits of the Irish Population.; 2008 [cited 2009 10 May]. Available from http://www.dohc.ie/publications/pdf/slan_summary.pdf?direct=1.
25.Micozzi, MS, Albanes, D. Three Limitations of the Body Mass Index. Am J Clin Nutrition 1988; 48: 691–2.
26.Heiskanen, T, Niskanen, L, Lyytikainen, R, Saarinen, P, Hintikka, J. Metabolic Syndrome in Patients With Schizophrenia. J Clin Psych 2003; 64: 575579.
27.Newcomer, JW, Haupt, DW. The Metabolic Effects of Antipsychotic Medications. Can J Psych 2006; 51: 480491
28.Garcia- Portilla, MPet al.The Prevalence of Metabolic Syndrome in Patients with Bipolar Disorder. J Affect Dis 2008; 106: 197201
29.Fagiolini, A, Frank, E, Scott, JA, Turkin, S, Kupfer, DJ. Metabolic Syndrome in Bipolar: Findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Dis 2005; 7: 424430.
30.Cormac, I, Ferriter, M, Martin, D. Improving the Physical Health of Long-stay Psychiatric Patients. Adv Psych Treatment 2004; 10: 107–15.
31.Lambert, TJR, Velakoulis, D, Pantelis, C. Medical Comorbidity in Schizophrenia. Schizophrenia 2003; 178: S67S70.
32.Carney, C, Allen, J, Doebbeling, M. Receipt of Clinical Preventive Medical Services among Psychiatric Patients. Psych Serv 2002; 53: 10281030.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed